* Xenetic Biosciences press release [https://seekingalpha.com/pr/20199235-xenetic-biosciences-inc-reports-second-quarter-2025-financial-results] (NASDAQ:XBIO [https://seekingalpha.com/symbol/XBIO]): Q2 Net loss for the quarter ended June 30, 2025 was approximately $0.7 million.
* Research & development expenses for the three months ended June 30, 2025 decreased by approximately $277,000, or 29.7%, to approximately $0.7 million from $0.9 million in the comparable quarter in 2024. General and administrative expenses for the three months ended June 30, 2025 decreased by approximately $472,000, or 41.8%, to approximately $0.7 million from approximately $1.1 million in the comparable quarter in 2024.
*
MORE ON XENETIC BIOSCIENCES
* Seeking Alpha’s Quant Rating on Xenetic Biosciences [https://seekingalpha.com/symbol/XBIO/ratings/quant-ratings]
* Historical earnings data for Xenetic Biosciences [https://seekingalpha.com/symbol/XBIO/earnings]
* Financial information for Xenetic Biosciences [https://seekingalpha.com/symbol/XBIO/income-statement]
Xenetic Biosciences reports Q2 results
Published 2 months ago
Aug 13, 2025 at 2:16 PM
Negative
Auto